Interferon-gamma decreases ATP-binding cassette subfamily G member 1-mediated cholesterol efflux through small ubiquitin-like modifier/ubiquitin-dependent liver X receptor-alpha degradation in macrophages

Mengya Dong,Yan Zhang,Chenbo Xu,Chen Wang,Mengping Liu,Zhanyi Zhang,Haoyu Wu,Zuyi Yuan,Juan Zhou
DOI: https://doi.org/10.1002/bab.2063
2021-01-01
Biotechnology and Applied Biochemistry
Abstract:The effects of interferon-gamma (IFN-gamma) on cholesterol accumulation and the development of foam cells are still unclear. In the present study, we found that IFN-gamma promoted liver X receptor (LXR)-alpha degradation through the ubiquitin-proteasome system in macrophages. The process was dependent on its interactions with phosphorylated signal transducer and activator of transcription 1 (p-STAT1) and protein inhibitor of activated STAT 1 (PIAS1) because both fludarabine and PIAS1 shRNA reversed the decrease in LXR-alpha protein expression induced by IFN-gamma. Additionally, IFN-gamma enhanced the interactions of ubiquitin-conjugating enzyme 9 (UBC9), small ubiquitin-like modifier (SUMO)-1 and SUMO-2/3 with LXR-alpha. Moreover, treatment with shRNA specific for them not only reduced LXR-alpha polyubiquitination but also reversed the IFN-gamma-induced decrease in its expression. Two specific sumoylation sites in LXR-alpha, K22 and K326, were indispensable for its IFN-gamma-induced polyubiquitination because the K22R and K326R mutations inhibited the polyubiquitination and degradation of LXR-alpha in IFN-gamma-treated macrophages. In addition, K22R or K326R mutation almost completely restored ATP-binding cassette subfamily G member 1 (ABCG1)-mediated cholesterol efflux in IFN-gamma-treated macrophages. Taken together, these findings indicate that IFN-gamma promotes LXR-alpha degradation through a SUMO-ubiquitin-dependent pathway, which may inhibit cholesterol efflux mediated by ABCG1 from macrophages and promote the development of atherosclerosis.
What problem does this paper attempt to address?